Potential Role of Akkermansia muciniphila in Parkinson's Disease and Other Neurological/Autoimmune Diseases

被引：18
|
作者：
Fang, Xin [1 ]
Li, Fang-jun [1 ]
Hong, Dao-jun [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China
来源：
CURRENT MEDICAL SCIENCE | 2021年 / 41卷 / 06期
基金：
中国国家自然科学基金;
关键词：
Akkermansia muciniphila; gut microbiota; neurological diseases; Parkinson's disease; INSULIN-RESISTANCE; GUT MICROBIOTA; INFLAMMATION;
D O I：
10.1007/s11596-021-2464-5
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The composition of the gut microbiota, including Akkermansia muciniphila (A. muciniphila), is altered in many neurological diseases and may be involved in the pathophysiological processes of Parkinson's disease (PD). A. muciniphila, a mucin-degrading bacterium, is a potential next-generation microbe that has anti-inflammatory properties and is responsible for keeping the body healthy. As the role of A. muciniphila in PD has become increasingly apparent, we discuss the potential link between A. muciniphila and various neurological diseases (including PD) in the current review.
引用
收藏
页码：1172 / 1177
页数：6
相关论文
共 50 条
  • [41] Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease
    Madhumitha Katta
    Blessy Aksa Mathew
    Pragya Chaturvedi
    Abhilash Ludhiadch
    Anjana Munshi
    Neurological Sciences, 2023, 44 : 19 - 36
  • [42] A Cost Model for Neurological Diseases in Puerto Rico: Parkinson's Disease, Alzheimer's Disease and Huntington's Disease
    Ortiz, Nicole J.
    Mendez, Mayra
    Aviles, Gabriela
    Roman, Cesar
    Narvaez-Cordero, Paula
    Valdes, Elizmarie
    Cabrera-Rios, Mauricio
    Isaza, Clara E.
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2023, 42 (02) : 146 - 151
  • [43] The role and therapeutic potential of connexins, pannexins and their channels in Parkinson's disease
    Ahmadian, Elham
    Eftekhari, Aziz
    Samiei, Mohammad
    Dizaj, Solmaz Maleki
    Vinken, Mathieu
    CELLULAR SIGNALLING, 2019, 58 : 111 - 118
  • [44] Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson's Disease
    Frahm, Niklas
    Hecker, Michael
    Zettl, Uwe Klaus
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (38) : 4008 - 4016
  • [45] Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease
    Katta, Madhumitha
    Mathew, Blessy Aksa
    Chaturvedi, Pragya
    Ludhiadch, Abhilash
    Munshi, Anjana
    NEUROLOGICAL SCIENCES, 2023, 44 (01) : 19 - 36
  • [46] Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease
    Danau, Adela
    Dumitrescu, Laura
    Lefter, Antonia
    Tulba, Delia
    Popescu, Bogdan Ovidiu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [47] Urolithin A in Health and Diseases: Prospects for Parkinson's Disease Management
    Wojciechowska, Olga
    Kujawska, Malgorzata
    ANTIOXIDANTS, 2023, 12 (07)
  • [48] Microbial treatment: the potential application for Parkinson's disease
    Fang, Xin
    NEUROLOGICAL SCIENCES, 2019, 40 (01) : 51 - 58
  • [49] Diagnostic potential of gut microbiota in Parkinson's disease
    Petrov, V. A.
    Alifirova, V. M.
    Saltykova, I., V
    Zhukova, I. A.
    Zhukova, N. G.
    Dorofeeva, Yu B.
    Ikkert, O. P.
    Titova, M. A.
    Mironova, Yu S.
    Sazonov, A. E.
    Karpova, M. R.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (04): : 92 - 101
  • [50] Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease
    Cantu-Jungles, Thaisa M.
    Rasmussen, Heather E.
    Hamaker, Bruce R.
    FRONTIERS IN NEUROLOGY, 2019, 10
12345